Effects of VEGF temporal and spatial presentation on angiogenesis

Eduardo Silva, David J. Mooney

Research output: Contribution to journalArticle

140 Citations (Scopus)

Abstract

Therapeutic angiogenesis relies on the delivery of angiogenic factors capable of reversing tissue ischemia. Polymeric materials that can provide spatial and temporal over vascular endothelial growth factor (VEGF) presentation provide clear benefit, but the influence of VEGF dose, temporal, and spatial presentation on the resultant angiogenic process are largely unknown. The influence of the temporal profile of VEGF concentration, dose, and the impact of VEGF spatial distribution on angiogenesis in in vitro models of angiogenesis and ischemic murine limbs was analyzed in this study. Importantly, a profile consisting of a high VEGF concentration initially, followed by a decreasing concentration over time was found to yield optimal angiogenic sprouting. A total VEGF dose 0.1 μg/g, when delivered with kinetics found to be optimal in vitro, provided a favorable therapeutic dose in murine hindlimb ischemia model, and distributing this VEGF dose in two spatial locations induces a higher level of vascularization and perfusion than a single location. These findings suggest that material systems capable of controlling and regulating the temporal and spatial presentation of VEGF maybe useful to achieve a robust and potent therapeutic angiogenic effect in vivo.

Original languageEnglish (US)
Pages (from-to)1235-1241
Number of pages7
JournalBiomaterials
Volume31
Issue number6
DOIs
StatePublished - Feb 1 2010
Externally publishedYes

Fingerprint

Vascular Endothelial Growth Factor A
Ischemia
Intercellular Signaling Peptides and Proteins
Angiogenesis Inducing Agents
Therapeutic Uses
Hindlimb
Spatial distribution
Extremities
Tissue
Kinetics
Polymers
Therapeutics

Keywords

  • Peripheral vascular diseases (PVD)
  • Poly(lactide-co-glycolide)
  • Polymer
  • Regenerative medicine
  • Sustained delivery
  • Synthetic extracellular matrices

ASJC Scopus subject areas

  • Biomaterials
  • Bioengineering
  • Ceramics and Composites
  • Mechanics of Materials
  • Biophysics

Cite this

Effects of VEGF temporal and spatial presentation on angiogenesis. / Silva, Eduardo; Mooney, David J.

In: Biomaterials, Vol. 31, No. 6, 01.02.2010, p. 1235-1241.

Research output: Contribution to journalArticle

Silva, Eduardo ; Mooney, David J. / Effects of VEGF temporal and spatial presentation on angiogenesis. In: Biomaterials. 2010 ; Vol. 31, No. 6. pp. 1235-1241.
@article{13c00e2eac8f453eb1605d6f2d30f6a0,
title = "Effects of VEGF temporal and spatial presentation on angiogenesis",
abstract = "Therapeutic angiogenesis relies on the delivery of angiogenic factors capable of reversing tissue ischemia. Polymeric materials that can provide spatial and temporal over vascular endothelial growth factor (VEGF) presentation provide clear benefit, but the influence of VEGF dose, temporal, and spatial presentation on the resultant angiogenic process are largely unknown. The influence of the temporal profile of VEGF concentration, dose, and the impact of VEGF spatial distribution on angiogenesis in in vitro models of angiogenesis and ischemic murine limbs was analyzed in this study. Importantly, a profile consisting of a high VEGF concentration initially, followed by a decreasing concentration over time was found to yield optimal angiogenic sprouting. A total VEGF dose 0.1 μg/g, when delivered with kinetics found to be optimal in vitro, provided a favorable therapeutic dose in murine hindlimb ischemia model, and distributing this VEGF dose in two spatial locations induces a higher level of vascularization and perfusion than a single location. These findings suggest that material systems capable of controlling and regulating the temporal and spatial presentation of VEGF maybe useful to achieve a robust and potent therapeutic angiogenic effect in vivo.",
keywords = "Peripheral vascular diseases (PVD), Poly(lactide-co-glycolide), Polymer, Regenerative medicine, Sustained delivery, Synthetic extracellular matrices",
author = "Eduardo Silva and Mooney, {David J.}",
year = "2010",
month = "2",
day = "1",
doi = "10.1016/j.biomaterials.2009.10.052",
language = "English (US)",
volume = "31",
pages = "1235--1241",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",
number = "6",

}

TY - JOUR

T1 - Effects of VEGF temporal and spatial presentation on angiogenesis

AU - Silva, Eduardo

AU - Mooney, David J.

PY - 2010/2/1

Y1 - 2010/2/1

N2 - Therapeutic angiogenesis relies on the delivery of angiogenic factors capable of reversing tissue ischemia. Polymeric materials that can provide spatial and temporal over vascular endothelial growth factor (VEGF) presentation provide clear benefit, but the influence of VEGF dose, temporal, and spatial presentation on the resultant angiogenic process are largely unknown. The influence of the temporal profile of VEGF concentration, dose, and the impact of VEGF spatial distribution on angiogenesis in in vitro models of angiogenesis and ischemic murine limbs was analyzed in this study. Importantly, a profile consisting of a high VEGF concentration initially, followed by a decreasing concentration over time was found to yield optimal angiogenic sprouting. A total VEGF dose 0.1 μg/g, when delivered with kinetics found to be optimal in vitro, provided a favorable therapeutic dose in murine hindlimb ischemia model, and distributing this VEGF dose in two spatial locations induces a higher level of vascularization and perfusion than a single location. These findings suggest that material systems capable of controlling and regulating the temporal and spatial presentation of VEGF maybe useful to achieve a robust and potent therapeutic angiogenic effect in vivo.

AB - Therapeutic angiogenesis relies on the delivery of angiogenic factors capable of reversing tissue ischemia. Polymeric materials that can provide spatial and temporal over vascular endothelial growth factor (VEGF) presentation provide clear benefit, but the influence of VEGF dose, temporal, and spatial presentation on the resultant angiogenic process are largely unknown. The influence of the temporal profile of VEGF concentration, dose, and the impact of VEGF spatial distribution on angiogenesis in in vitro models of angiogenesis and ischemic murine limbs was analyzed in this study. Importantly, a profile consisting of a high VEGF concentration initially, followed by a decreasing concentration over time was found to yield optimal angiogenic sprouting. A total VEGF dose 0.1 μg/g, when delivered with kinetics found to be optimal in vitro, provided a favorable therapeutic dose in murine hindlimb ischemia model, and distributing this VEGF dose in two spatial locations induces a higher level of vascularization and perfusion than a single location. These findings suggest that material systems capable of controlling and regulating the temporal and spatial presentation of VEGF maybe useful to achieve a robust and potent therapeutic angiogenic effect in vivo.

KW - Peripheral vascular diseases (PVD)

KW - Poly(lactide-co-glycolide)

KW - Polymer

KW - Regenerative medicine

KW - Sustained delivery

KW - Synthetic extracellular matrices

UR - http://www.scopus.com/inward/record.url?scp=72149100455&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=72149100455&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2009.10.052

DO - 10.1016/j.biomaterials.2009.10.052

M3 - Article

C2 - 19906422

AN - SCOPUS:72149100455

VL - 31

SP - 1235

EP - 1241

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

IS - 6

ER -